Effectiveness of renin-angiotensin-aldosterone system blockers in patients with Alport syndrome: a systematic review and meta-analysis.

Mengyao ZengHongling DiJu LiangZhi-Hong Liu

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)

This meta-analysis suggested that RAAS blockers could be considered as a specific therapy to delay of ESKD for AS with any genetic type, especially at the early stage of the disease, and every further more-effective-therapy would be advised to be applied on top of this standard of care.

Keyphrases

angiotensin converting enzyme
systematic review
early stage
angiotensin ii
healthcare
randomized controlled trial
palliative care
meta analyses
quality improvement
gene expression
stem cells
squamous cell carcinoma
bone marrow
chronic pain
copy number
sentinel lymph node
lymph node